Autoimmune Hemolytic Anemia: A Case Study Presentation

Clin J Oncol Nurs. 2021 Dec 1;25(6):633-636. doi: 10.1188/21.CJON.633-636.

Abstract

Autoimmune hemolytic anemia (AIHA) is a rare and potentially life-threatening condition. This article presents a case study of AIHA in a patient with a history of acute myelogenous leukemia in remission. Differentiating the cause and type of HA (extrinsic versus intrinsic) will be discussed, along with information on follow-up and refractory AIHA. Advanced practice RNs (APRNs) play an essential role in the early recognition of HA, as well as the diagnosis, referral, and management of the condition.

Keywords: anemia; autoimmune disease; hematology; hemolytic; refractory; splenectomy.

MeSH terms

  • Anemia, Hemolytic, Autoimmune* / diagnosis
  • Anemia, Hemolytic, Autoimmune* / etiology
  • Anemia, Hemolytic, Autoimmune* / therapy
  • Humans
  • Rituximab
  • Splenectomy / adverse effects

Substances

  • Rituximab